Juergen Wolf
MD
Director, Center for Integrated Oncology
👥Biography 个人简介
Juergen Wolf directs the Center for Integrated Oncology in Cologne and has been instrumental in the clinical development of tepotinib for MET exon 14 skipping NSCLC. He led the VISION trial that secured regulatory approval for tepotinib globally. His molecular tumor board model has become a blueprint for precision oncology in Europe.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Juergen Wolf 的研究动态
Follow Juergen Wolf's research updates
留下邮箱，当我们发布与 Juergen Wolf（University Hospital Cologne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment